ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
21.00
+0.08 (0.38%)
Apr 29, 2025, 2:07 PM EDT - Market open
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $714.34 million as of April 29, 2025. Its market cap has increased by 20.70% in one year.
Market Cap
714.34M
Enterprise Value
492.93M
1-Year Change
20.70%
Ranking
Category
Stock Price
$21.00
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $714.34M, an increase of 24.19%. That is a compound annual growth rate of 18.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 711.62M | -20.73% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |